301211 亨迪药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额48,959137,063250,795123,984121,672
投资活动产生之现金流量净额(1,085,211)(207,469)(179,865)229,64744,351
筹资活动产生之现金流量净额(138,240)(97,168)(77,390)1,405,139(123,369)
汇率变动对现金及现金等价物的影响9113,8104,935(4,421)(2,760)
现金及现金等价物净增加/(减少)(1,173,581)(163,762)(1,526)1,754,34939,895
期初现金及现金等价物余额1,694,3271,857,9891,859,515105,16565,271
期末现金及现金等价物余额520,7451,694,2271,857,9891,859,515105,165